Flonoltinib 75mg

DRUG3 trials

Sponsors

Chengdu Zenitar Biomedical Technology Co., Ltd

Conditions

MFPolycythemia Vera (PV)

Phase 1

Material Balance Study of [14C] Flonoltinib Maleate

Not yet recruitingNCT07612306

Chengdu Zenitar Biomedical Technology Co., LtdMF

Start: 2026-06-30End: 2026-12-30Target: 6Updated: 2026-05-28

Phase 2

Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

RecruitingNCT07232290

Chengdu Zenitar Biomedical Technology Co., LtdPolycythemia Vera (PV)

Start: 2025-09-23End: 2028-02-28Target: 60Updated: 2026-03-04

Phase 3

A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis

RecruitingNCT07317700

Chengdu Zenitar Biomedical Technology Co., LtdMF

Start: 2026-02-13End: 2028-03-30Target: 105Updated: 2026-03-04